Found 1279 clinical trials
Respiratory Syncytial Virus (RSV) Vaccine
The study will enroll up to 23,000 participants in order to demonstrate the efficacy of the active Ad26.RSV.preF-based study vaccine in the prevention of Reverse Transcription Polymerase Chain Reaction (RT-PCR) confirmed Respiratory Syncytial Virus (RSV)-mediated Lower Respiratory Tract Disease (LRTD) when compared to placebo in adults aged 60 years and …
- 0 views
- 02 Feb, 2022
- 1 location
Healthy Volunteers (aged 18-40) needed for a Vaccine medical research study
Healthy Volunteers (aged 18-40) needed for a Vaccine medical research study
- 1580 views
- 23 Nov, 2020
- 1 location
C diffense - Clostridium Difficile Vaccine Trial
C diffense - Clostridium Difficile Vaccine Trial
- 294 views
- 08 Nov, 2020
- 1 location
The Flu Stinks, So Protect Yourself!
The Flu Stinks, So Protect Yourself!
- 47 views
- 08 Nov, 2020
- 1 location
Efficacy, Immunogenicity, and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection
Efficacy, Immunogenicity, and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection
- 228 views
- 25 Mar, 2021
- 1 location
Wake Research is enrolling volunteers in a research study testing the safety and effectiveness of an investigational vaccine for Herpes (HSV).
Wake Research is enrolling volunteers in a research study testing the safety and effectiveness of an investigational vaccine for Herpes (HSV).
- 2048 views
- 09 Jun, 2020
- 1 location
Flu Vaccine (FDA Approved) and RSV Vaccine study. - F6000
Flu Vaccine (FDA Approved) and RSV Vaccine Study. Receive up to $975 in compensation and study related care. If you are 60 years old or older you may be eligible to receive a Flu Vaccine (FDA Approved) and an RSV Vaccine at no cost. Compensation: Compensation for up to $975 …
- 0 views
- 09 Jun, 2022
- 1 location
Pneumonia Vaccine
Are you due for a pneumonia vaccine and a COVID Booster? The team at AMR Kansas City are now enrolling healthy volunteers in an investigational pneumonia vaccine clinical research study.
- 28 views
- 23 Dec, 2021
- 1 location
Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly with Routine Infant Vaccines to Healthy Infants
The purpose of this study is to evaluate the safety and immunogenicity of Bexsero (meningococcal group B vaccine-rMenB+OMV NZ) in North American infants 6 weeks through 12 weeks of age, when administered concomitantly with Pneumococcal conjugate vaccine (PCV 13) and other recommended routine infant vaccines (RIV).
- 0 views
- 24 Jun, 2022
- 1 location